HosseinTabrizianiMDFACP , FASN

Nephrology • San Diego, CA

Kidney & Pancreas Transplantation

Transplant Nephrologist

Join to view full profile

Dr. Tabriziani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tabriziani's full profile

Already have an account?

Office
HossMed, Inc
San Diego, CA 92101

Education & Training

University of California (San Francisco) School of MedicineFellowship, Transplsnt, 2012 - 2013
MedStar Health/Georgetown University HospitalFellowship, Nephrology, 2010 - 2012
St Barnabas HospitalResidency, Internal Medicine, 1999 - 2002
Iran University of Medical SciencesClass of 1995

Certifications & Licensure

CA State Medical License 2002 - 2025
IL State Medical License 2020 - 2023
DC State Medical License 2010 - 2018
NY State Medical License 2009 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

FASN ASN , American Society of Nephrology, 2015
FACP ACP , American College of Physician, 2008
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

29 citations
Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation.
Philip F Halloran, Jeff Reeve, Katelynn S Madill-Thomsen, Navchetan Kaur, Ebad Ahmed
Transplantation. 2022-12-01
18 citations
Using both the Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection.
Suphamai Bunnapradist, Piyavadee Homkrailas, Ebad Ahmed, Gordon Fehringer, Paul Billings
Journal of the American Society of Nephrology. 2021-06-23
12 citations
Cardiac risk assessment for end-stage renal disease patients on the renal transplant waiting list
Hossein Tabriziani, Pedro Baron, Islam Abudayyeh, Michael S. Lipkowitz
Clinical Kidney Journal. 2019-08-01

Press Mentions

Natera Announces Definitive Study to Evaluate the Clinical Utility of Renasight in the Diagnosis and Management of Chronic Kidney Disease (CKD)April 28th, 2022
Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect ConferenceJune 4th, 2021
Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect ConferenceJune 4th, 2021